AVEO Pharmaceuticals Inc. (AVEO)

0.58
NASDAQ : Health Technology
Prev Close 0.62
Day Low/High 0.57 / 0.62
52 Wk Low/High 0.49 / 3.59
Avg Volume 3.59M
Exchange NASDAQ
Shares Outstanding 139.00M
Market Cap 86.37M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Names Flexing Their Muscles

Biotech Names Flexing Their Muscles

There's action in Global Blood Therapeutics and Antares Pharma.

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I've Prepared for Hurricane Irma -- and a Market Pullback

As a Miami resident, I've learned the value of hurricane preparation and the 'Jensen Rules'.

How I'm Prepared for Irma -- and a Pullback

How I'm Prepared for Irma -- and a Pullback

As a Florida resident, I've learned the value of preparation and the 'Jensen Rules'.

When Eyeing Small Biotechs, Partnerships Are Huge

When Eyeing Small Biotechs, Partnerships Are Huge

Key collaboration deals with deeper-pocketed concerns can improve the odds of investment success.

Playing Biotechs with the House's Money

Playing Biotechs with the House's Money

Here's how to lock in gains on risky small-cap biotechnology stocks.

A Few Bright Spots Liven Up a Slow Week

I'm happy to once again be sitting in for Doug Kass today. It's been a remarkably boring week, with the major indices all trading in a narrow range. It feels like investors are unsure of stocks' next direction following first-quarter earnings season...

Jobs Report Aftermath

The market sold off in morning trading, despite a better-than-expected jobs report that showed new job creation of 295,000 for February and saw the unemployment rate falling again, to 5.5%. Wage growth is still not benefiting from stronger job growt...

Rare Good News for Mortgage Servicers

The market is clawing its way back to even. Oil is holding gains, and this is translating into solid gains within the E&P space today so far. This is also helping Chicago Bridge & Iron (CBI) recover some of its losses from announcement of another de...

Slim Pickings in Latest 13F Filings

Many value investors are making more concentrated bets.

Shotgun Investing in Biotech

Shotgun Investing in Biotech

Two speculative plays are worthy of consideration.

Another Gem for the Biotech Basket

Amid the basket's impressive performance, I'm adding Minerva.

Building a Biotech Basket

Borrowing a page from a master investor's playbook.

5 Dumbest Things on Wall Street

5 Dumbest Things on Wall Street

Scotts Miracle-No!, Synta's Sorrow and Google's Porn Problem highlight Gregg Greenberg's 5 Dumbest list this week.

Biotech's Next Big Thing: Aveo

Biotech's Next Big Thing: Aveo

TheStreet Sr. Columnist Adam Feuerstein says FDA reviews for cancer drugs from Aveo and Delcath are the next big thing in biotech.

Shake the Bushes

I'm looking for the hot themes or groups of 2013.

Put These Flyers Under Your Tree

These stocks may be speculative, but they sport solid sales-growth estimates -- and insiders are buying.  

Walking Away From the Cliff

Some traders are shutting down for the year rather than trying to game the fiscal cliff.

Next Big Thing in Biotech: Cancer Drug Stocks

Next Big Thing in Biotech: Cancer Drug Stocks

Senior columnist Adam Feuerstein explains why cancer drug stocks are the next big thing in biotech.